grant

Bone Quality Assessment with a Novel Three-Bore Magnet Extremity MRI Scanner

Organization MASSACHUSETTS GENERAL HOSPITALLocation BOSTON, UNITED STATESPosted 1 Feb 2020Deadline 30 Nov 2026
NIHUS FederalResearch GrantFY20253-D3-Dimensional3DAbnormal Assessment of MetabolismAddressAgeAmericanAnatomic AbnormalityAnatomical AbnormalityAnimalsBiologicalBiological MarkersBlood SerumBone DensityBone MatrixBone Mineral DensityCalibrationCapitalCell Communication and SignalingCell SignalingCessation of lifeChemicalsClinicClinical DataClinical ResearchClinical StudyClinical TrialsCoupledDEXADXADataDeathDedicationsDeformityDevelopmentDiagnosisDiagnosticDiseaseDisorderDual-Energy X-Ray AbsorptiometryDual-Energy Xray AbsorptiometryElderlyExtremitiesFundingFutureGenderGenerationsGoalsH+ elementHealthHealth systemHumanHydrogen IonsImageImaging ProceduresImaging TechnicsImaging TechniquesIntracellular Communication and SignalingIonizing Electromagnetic RadiationIonizing radiationJointsKnowledgeLaboratoriesLegLimb structureLimbsMR ImagingMR TomographyMRIMRI ScansMRIsMagnetic Resonance ImagingMagnetic Resonance Imaging ScanMeasurementMeasuresMedical Imaging, Magnetic Resonance / Nuclear Magnetic ResonanceMetabolic Bone DiseasesMetabolic StudiesMetabolism StudiesMethodologyMethodsMineralsModern ManNMR ImagingNMR TomographyNational Institutes of HealthNoiseNon-TrunkNuclear Magnetic Resonance ImagingOsteomalaciaOsteoporosisPainPainfulPatientsPerformancePeripheralPhosphorousPhosphorusPhysiologic pulsePost-MenopausePost-menopausal PeriodPostmenopausal PeriodPostmenopauseProtonsPublic HealthPulseRF coilRadiation DoseRadiation Dose UnitRadiation exposureRadiation-Ionizing TotalRenal OsteodystrophyResearch SpecimenResolutionSafetyScanningSerumSignal TransductionSignal Transduction SystemsSignalingSocietiesSolidSpecimenTechniquesTechnologyTestingTimeUnited StatesUnited States National Institutes of HealthWomanWritingZeugmatographyaccurate diagnosisaccurate diagnosticsadvanced ageafter menopauseagesanimal tissuearmbio-markersbiologicbiologic markerbiological signal transductionbiomarkerbonebone fragilitybone imagingbone metabolism disorderbone qualitybone scanningcohortcostdensitydesigndesign and constructdesign and constructiondesigningdetection of osteoporosisdetermine efficacydevelopmentaldiagnosed with osteoporosisdiagnostic for Osteoporosisdiagnostic paneleconomic costefficacy analysisefficacy assessmentefficacy determinationefficacy evaluationefficacy examinationevaluate efficacyexamine efficacyexperimentexperimental researchexperimental studyexperimentsfollowing menopausefracture riskfragility fracturegeriatrichealthy volunteerimage constructionimage generationimage reconstructionimagingindividuals with osteoporosisionizing outputmetabolic abnormality assessmentmetabolic bone diseasemetabolic bone disordermineralizationnetwork architecturenovelolder adultolder adulthoodosteoporosis diagnosisosteoporosis individualsosteoporosis patientsosteoporosis peopleosteoporosis populationosteoporotic diagnosisosteoporotic individualosteoporotic patientsosteoporotic populationpast menopausepatients with osteoporosispeople with osteoporosispopulation with osteoporosispost-menopausalpostmenopausalpostmenopausal statusreconstructionresolutionsscreeningscreeningssenior citizenskeletalskeletal imagingsoft tissuesolid statestemtech developmenttechnology developmentthree dimensional
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Osteoporosis and related metabolic bone diseases are nearly universal problems associated with advanced
age, particularly for postmenopausal women, expecting to cost society over $22 billion annually by 2020, and

leading to 65,000 deaths each year stemming from bone fragility fractures. Recent studies have demonstrated

that MRI may be of particular utility for addressing several factors related to bone quality that can only be

measured with difficulty in patients. High spatial resolution MRI can be used to accurately characterize

trabecular microarchitecture, and follow it with treatment, without the attendant ionizing radiation dose of DXA

or CT. Solid state MRI can uniquely measure the organic bone matrix content noninvasively as well as the

mineral. Proton (1H) solid state MRI has been used to measure bone matrix, while phosphorus (31P) solid state

MRI has potential to accurately assess 3D bone mineral density. Combining these two measurements in a

single simultaneous measurement could facilitate a more informative diagnostic for metabolic bone disease,

especially if coupled with high spatial resolution 3D trabecular imaging.

MRI is an expensive measurement, and not justified for screening for or diagnosing metabolic bone

disease. However, if the cost of MRI could be drastically reduced, such measurements could become

financially competitive with DXA while providing significantly increased diagnostic information content, and at

the same time completely eliminating ionizing radiation exposure.

In this project, we will develop the methodology of MRI characterization of metabolic bone disease using a

unique dedicated inexpensive, compact, cryogen-free extremity MRI scanner designed and constructed in a

previous NIH-funded project. Notably, the magnet of this scanner has been designed for comfortable and

efficacious extremity scanning, and in particular contains three bores: a central bore that is the “active” bore in

which the limb being scanned is inserted, and two peripheral “nonactive” bores that comfortably accept the leg

not being scanned. Both the capital and operating costs of this scanner, as well as the clinic “real estate” it

occupies, are drastically lower than for the typical whole body scanner. As of this writing, a second generation

compact tiltable magnet with multiple openings may arrive in the PI's lab by the beginning of this project.

The specific aims are: 1) Further the technical development of high spatial resolution 3D MRI of trabecular

network architecture, and solid state proton and phosphorus MRI for quantitative bone mineral and matrix

measurement; 2) Assess the quantitative accuracy of solid state MRI for these measurements in phantoms,

animal tissues, and live animals; 3) Evaluate the repeatability and accuracy of high spatial resolution and solid

state MRI scanning in healthy volunteer subjects; and 4) Carry out studies of metabolic bone disease patients

and age- and gender-matched normals to make a preliminary assessment of the accuracy of MRI-based bone

characterization, and to acquire statistical information that will permit the design of future clinical trials.

Grant Number: 5R01AR075077-05
NIH Institute/Center: NIH

Principal Investigator: JEROME ACKERMAN

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →